san antonio heights semaglutide weight loss Medical Weight Loss San Antonio

The dosing protocols and how they compare to clinical guidelines

Semaglutide is primarily approved for managing obesity and weight-related health conditions, but it may also be considered for individuals experiencing medically significant weight gain due to other factors, such as medication side effects

GLP-1s have become a popular medication so much so that, for a couple of years, there was a national shortage

The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect

Common side effects may include: Rare but possible risks include: Our providers monitor every patient closely and adjust treatment as needed to minimize risks

Medicaid hardly pays for any weight loss agents, and Medicare is prohibited from doing so